TUESDAY, July 15, 2025 -- In postmenopausal women with overweight or obesity receiving tirzepatide, use of menopausal hormone therapy (MHT) is...
Vous n'êtes pas connecté
MONDAY, July 8, 2024 -- Tirzepatide is associated with significantly greater weight loss than semaglutide for adults with overweight or obesity, according to a study published online July 8 in JAMA Internal Medicine.Patricia J. Rodriguez, Ph.D...
TUESDAY, July 15, 2025 -- In postmenopausal women with overweight or obesity receiving tirzepatide, use of menopausal hormone therapy (MHT) is...
TUESDAY, July 15, 2025 -- For adults with overweight or obesity, certain factors might influence weight loss after taking glucagon-like peptide 1...
THURSDAY, July 10, 2025 -- Use of cannabidiol (CBD) within the range consumers are taking with unregulated CBD products is associated with increased...
Using tirzepatide and menopause hormone therapy at the same time leads to increased weight loss in postmenopausal women with overweight or obesity...
Concurrent lifestyle intervention was associated with greater weight loss in people with overweight or obesity receiving semaglutide treatment and...
Concurrent lifestyle intervention was associated with greater weight loss in people with overweight or obesity receiving semaglutide treatment and...
WEDNESDAY, July 9, 2025 -- Hearing rehabilitation with hearing aids or cochlear implants is associated with improved social outcomes for older adults...
THURSDAY, July 3, 2025 -- Greater neighborhood disadvantage is associated with increased inflammatory and Alzheimer disease (AD) cerebrospinal fluid...
THURSDAY, July 3, 2025 -- For adults with overweight or obesity, time-restricted eating (TRE) does not lead to significant changes in sleep, mood, or...
WEDNESDAY, July 16, 2025 -- Anticholinergics are associated with physical performance decline in older adults, according to a study published online...